AFRIXIME

This brand name is authorized in Nigeria.

Active ingredients

The drug AFRIXIME contains one active pharmaceutical ingredient (API):

1	Cefixime UNII 97I1C92E55 - CEFIXIME
	Cefixime is an oral third generation cephalosporin which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms.
	Read more about Cefixime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-0629	Tablet	Afrixime 200 Tablet TAB 200 mg	Each tablet contains: Cefixime (as Cefixime Trihydrate USP) 200 mg	21/12/2020
B4-0909	Tablet	Afrixime 100 Tablet TAB 100 mg	Each tablet contains: Cefixime Trihydrate equiv. to Cefixime 100 mg	20/12/2019
B4-1476	Powder for suspension	Afrixime Powder for Oral Suspension PWD_F_SOL 50 mg/5 mL	Powder for Oral Suspension. Each 5 mL reconstituted suspension contains: Cefixime (as Cefixime Trihydrate USP) 50 mg	21/12/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD08	Cefixime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-0629, B4-0909, B4-1476